VYCOR MEDICAL INC (VYCO) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US92921M2035
VYCOR MEDICAL INC financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.86 m USD |
| Gross profit | 1.56 m USD |
| Operating income | 33,900.00 USD |
| EBIT | -72,426.00 USD |
| Net income | -72,426.00 USD |
| Diluted EPS – continuing operations | -0.01 USD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About VYCOR MEDICAL INC
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation therapies targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a German-based partner. It primarily serves hospitals and medical professionals. The company was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. operates as a subsidiary of Fountainhead Capital Management Ltd.
More stocks
- TOFUTTI BRANDS INC (TOFB)
- iSpecimen Inc. (ISPC)
- PROCYON CORP (PCYN)
- SILVER BULL RESOURCES, INC. (SVBL)
- Tego Cyber, Inc. (TGCB)
- GLOBAL TECHNOLOGIES LTD (GTLL)
- Ranger Gold Corp. (RNGC)
- Cleartronic, Inc. (CLRI)
- NUTRA PHARMA CORP (NPHC)
- CANNAPHARMARX, INC. (CPMD)
- Pony Group Inc. (PNYG)
- FUSE GROUP HOLDING INC. (FUST)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.